Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis

Osteosarcoma is a common malignant tumor in children and adolescents, known for its aggressive invasion and distant metastasis, leading to a poor prognosis. Matrix metalloproteinases (MMPs) can degrade the extracellular matrix and basement membranes through their proteolytic activity, thereby promot...

Full description

Bibliographic Details
Main Authors: Yu-Hsiang Chang, Yuan-Li Huang, Hsiao-Chi Tsai, An-Chen Chang, Chih-Yuan Ko, Yi-Chin Fong, Chih-Hsin Tang
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/10/2768
_version_ 1797574621822713856
author Yu-Hsiang Chang
Yuan-Li Huang
Hsiao-Chi Tsai
An-Chen Chang
Chih-Yuan Ko
Yi-Chin Fong
Chih-Hsin Tang
author_facet Yu-Hsiang Chang
Yuan-Li Huang
Hsiao-Chi Tsai
An-Chen Chang
Chih-Yuan Ko
Yi-Chin Fong
Chih-Hsin Tang
author_sort Yu-Hsiang Chang
collection DOAJ
description Osteosarcoma is a common malignant tumor in children and adolescents, known for its aggressive invasion and distant metastasis, leading to a poor prognosis. Matrix metalloproteinases (MMPs) can degrade the extracellular matrix and basement membranes through their proteolytic activity, thereby promoting osteosarcoma metastasis. Chemokine ligand 2 (CCL2) is a well-studied chemokine that plays a significant role in the cell motility of many cancers. However, its specific involvement in osteosarcoma metastasis is not fully understood. The aim of this study is to examine the role of miRNAs in CCL2-mediated MMP expression and cell motility in human osteosarcoma. The analysis of immunohistochemistry data and databases associated a positive correlation between CCL2 or MMP-3 levels with the metastasis of osteosarcoma patients. The in vivo lung metastatic osteosarcoma model also demonstrated similar effects, showing higher levels of CCL2 and MMP-3 in lung metastatic osteosarcoma tissues. The stimulation of osteosarcoma cells with CCL2 enhanced migration and invasion abilities through the upregulation of MMP-3 synthesis. Our results also indicate that CCL2 enhances MMP-3-dependent cell motility by inhibiting miR-3659 synthesis. Therefore, CCL2 represents a promising therapeutic target for treating metastasis in osteosarcoma.
first_indexed 2024-03-10T21:24:55Z
format Article
id doaj.art-df841b39091645f3879556f4fb4396dc
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T21:24:55Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-df841b39091645f3879556f4fb4396dc2023-11-19T15:46:49ZengMDPI AGBiomedicines2227-90592023-10-011110276810.3390/biomedicines11102768Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 AxisYu-Hsiang Chang0Yuan-Li Huang1Hsiao-Chi Tsai2An-Chen Chang3Chih-Yuan Ko4Yi-Chin Fong5Chih-Hsin Tang6Program for Cancer Biology and Drug Discovery, China Medical University, Taichung 404328, TaiwanDepartment of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, TaiwanDepartment of Medical Education and Research, China Medical University Beigang Hospital, Yunlin 651012, TaiwanTranslational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111045, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404328, TaiwanDepartment of Orthopedic Surgery, China Medical University Hospital, Taichung 404327, TaiwanProgram for Cancer Biology and Drug Discovery, China Medical University, Taichung 404328, TaiwanOsteosarcoma is a common malignant tumor in children and adolescents, known for its aggressive invasion and distant metastasis, leading to a poor prognosis. Matrix metalloproteinases (MMPs) can degrade the extracellular matrix and basement membranes through their proteolytic activity, thereby promoting osteosarcoma metastasis. Chemokine ligand 2 (CCL2) is a well-studied chemokine that plays a significant role in the cell motility of many cancers. However, its specific involvement in osteosarcoma metastasis is not fully understood. The aim of this study is to examine the role of miRNAs in CCL2-mediated MMP expression and cell motility in human osteosarcoma. The analysis of immunohistochemistry data and databases associated a positive correlation between CCL2 or MMP-3 levels with the metastasis of osteosarcoma patients. The in vivo lung metastatic osteosarcoma model also demonstrated similar effects, showing higher levels of CCL2 and MMP-3 in lung metastatic osteosarcoma tissues. The stimulation of osteosarcoma cells with CCL2 enhanced migration and invasion abilities through the upregulation of MMP-3 synthesis. Our results also indicate that CCL2 enhances MMP-3-dependent cell motility by inhibiting miR-3659 synthesis. Therefore, CCL2 represents a promising therapeutic target for treating metastasis in osteosarcoma.https://www.mdpi.com/2227-9059/11/10/2768osteosarcomaCCL2MMP-3metastasismiR-3659
spellingShingle Yu-Hsiang Chang
Yuan-Li Huang
Hsiao-Chi Tsai
An-Chen Chang
Chih-Yuan Ko
Yi-Chin Fong
Chih-Hsin Tang
Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
Biomedicines
osteosarcoma
CCL2
MMP-3
metastasis
miR-3659
title Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
title_full Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
title_fullStr Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
title_full_unstemmed Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
title_short Chemokine Ligand 2 Promotes Migration in Osteosarcoma by Regulating the miR-3659/MMP-3 Axis
title_sort chemokine ligand 2 promotes migration in osteosarcoma by regulating the mir 3659 mmp 3 axis
topic osteosarcoma
CCL2
MMP-3
metastasis
miR-3659
url https://www.mdpi.com/2227-9059/11/10/2768
work_keys_str_mv AT yuhsiangchang chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT yuanlihuang chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT hsiaochitsai chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT anchenchang chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT chihyuanko chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT yichinfong chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis
AT chihhsintang chemokineligand2promotesmigrationinosteosarcomabyregulatingthemir3659mmp3axis